相关实验视频

Updated: May 10, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

在化后辅助接种疫苗,用于治疗宫发育不良

Carlotta Caia¹, Francesca De Maria¹, Francesco Sopracordevole²

¹Gynecologic Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

|April 25, 2025

概括

在宫发育不良症的结合后,辅助性人类乳头瘤病毒 (HPV) 疫苗接种并没有显著影响本研究中的复发或重复程序的需要. 需要进一步的研究来澄清它的作用.

科学领域:

妇科妇科医生妇科
在瘤学瘤学.
疫苗学疫苗学疫苗学

背景情况:

宫内皮质瘤 (CIN) 是一种癌前疾病,通常用结治疗.
人类乳头瘤病毒 (HPV) 是导致宫发育不良的主要原因.
辅助性HPV疫苗接种在感染后的作用尚未完全确定.

研究的目的:

为了评估辅助性HPV疫苗接种在女性高度宫发育不良后的有效性.
评估HPV疫苗接种对复发率和重新接种需要的影响.

主要方法:

一项前性研究比较了281名接受化治疗的妇女,113名接受了辅助性HPV疫苗接种和观察,168名仅进行观察.
分析影响复发的因素,包括手术边缘,随访时间和重新治疗的需要.
多变量分析以确定HPV疫苗接种对术后结果的影响.

主要成果:

接种疫苗的患者年龄较小 (38岁与45岁相比),外科手术利率较高 (9.7%与3.6%相比).
两组之间没有与HPV相关的病变发展 (P=0.594) 或需要重新治疗 (P=0.593) 的显著差异.
多变量分析显示,HPV疫苗接种对短期结果没有显著影响 (HR:0.50对于任何病变,HR:0.90对于重新感染).

结论:

辅助性HPV疫苗似乎不会显著改变为宫发育不良而接受化治疗的妇女的短期结果.
目前的研究结果表明,在这种特定的辅助环境中,接种疫苗可能无法预防复发.
来自随机对照试验的进一步证据是必要的,以确定辅助HPV疫苗的作用.

关键词:

一个辅助的辅助者.子宫HPV 病毒感染.化 (conization) 是一种形式.接种疫苗接种疫苗

更多相关视频

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.